-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Galectin Therapeutics Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Galectin Therapeutics Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$11.3M, a 25.4% decline year-over-year.
- Galectin Therapeutics Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$39.7M, a 4.11% decline year-over-year.
- Galectin Therapeutics Inc annual Operating Income (Loss) for 2023 was -$38.1M, a 0.73% increase from 2022.
- Galectin Therapeutics Inc annual Operating Income (Loss) for 2022 was -$38.4M, a 27.1% decline from 2021.
- Galectin Therapeutics Inc annual Operating Income (Loss) for 2021 was -$30.2M, a 28.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)